How Should You Code a Secondary Malignant Neoplasm When Cancer Has Spread to Another Site?
"A patient has cancer that has spread from the original site to another part of the body. How do we determine which ICD-10-CM code to use for the secondary malignant neoplasm, and how should the primary cancer be handled?"
When a malignancy has spread, start by separating two concepts:
1. Primary Site
Where did the cancer originate?
2. Secondary Site
Where has it metastasized?
Don’t assume that cancer documented at two sites automatically means one is metastatic to the other. Review the documentation for terms and clinical statements that establish the relationship between the malignancies.
When the documentation supports a secondary malignancy, select the ICD-10-CM code that most specifically identifies the metastatic site. Then determine whether the primary malignancy is still active, has been eradicated, or is otherwise addressed under applicable ICD-10-CM guidelines.
The Central Rule
Identify the Primary Site → Identify the Secondary Site → Confirm the Relationship → Determine Current Cancer Status → Verify and Sequence the Codes
What Is a Secondary Malignant Neoplasm?
A secondary malignant neoplasm occurs when malignant cells spread from the original cancer site to another part of the body. You may also see documentation using terms such as:
Metastatic | Metastasis | Secondary | Spread to
The exact language in the record can vary, but the important coding question is whether the documentation establishes that the malignancy at the new site originated elsewhere.
That distinction matters because a malignancy at a particular anatomical location could represent either a primary cancer originating at that site or a secondary malignancy that spread there from another site. Those aren’t the same diagnosis.
Don’t Assume the Second Cancer Is Metastatic
Suppose a patient has a documented history of breast cancer and now has a malignant neoplasm involving the lung. Can you automatically code secondary malignant neoplasm of the lung? No.
The patient could have metastatic breast cancer involving the lung, but the patient could also have a new primary lung cancer. Those clinical circumstances lead to different coding.
Look for documentation establishing the relationship rather than making the connection because it appears medically plausible. If the provider hasn’t clearly established whether the new malignancy is primary or secondary and the distinction is necessary for accurate coding, clarification may be appropriate.
Don’t Assume the Primary Site From the Secondary Site
The reverse can also happen. The documentation clearly states that a patient has metastatic disease at a particular site, but the primary cancer isn’t identified. Don’t choose a primary site based on where you believe that type of cancer usually originates.
The secondary malignancy can still be coded according to the documentation and applicable ICD-10-CM guidelines, while the primary site should be handled based on what is actually known and documented. Coding should reflect the patient’s record—not a statistical probability.
Look for Documentation That Establishes the Relationship
The strongest documentation makes the cancer relationship clear.
Example 1
“Colon cancer metastatic to liver.”
That gives you both pieces of information. The colon is the primary site. The liver is the secondary site.
Example 2
“History of colon cancer. Liver malignancy.”
That statement doesn’t necessarily establish that the liver malignancy is metastatic colon cancer. The difference may appear small from a documentation standpoint, but it can be significant for coding.
Don’t turn two separate facts into a clinical relationship the provider hasn’t established.
Code the Secondary Site as Specifically as the Documentation Supports
Once the documentation establishes a secondary malignancy, determine whether ICD-10-CM provides a code specifically identifying the metastatic site. Anatomical specificity matters.
Secondary malignancies can involve locations such as bone, brain, liver, lung, lymph nodes, or other organs and tissues. Depending on the site, ICD-10-CM may provide additional distinctions. Don’t automatically settle for a broad secondary-malignancy code when the record supports something more specific.
But the opposite rule is equally important: Don’t create anatomical specificity that isn’t documented.
The most detailed code isn’t necessarily the most accurate code. The most detailed supported code is.
Is the Primary Cancer Still Active?
Finding a secondary malignancy doesn’t answer every coding question. You also need to understand the status of the primary cancer.
If the original malignancy is still active, an active malignant-neoplasm code may remain appropriate.
If the primary malignancy has been eradicated and there is no further treatment directed to that site and no evidence of existing primary malignancy there, applicable ICD-10-CM guidance may instead point toward a personal-history code for the former primary site.
That distinction deserves careful attention. A patient can have a history of a primary malignancy while simultaneously having an active secondary malignancy. “History of cancer” doesn’t necessarily mean the patient has no active cancer anywhere.
Don’t Turn an Active Cancer Into a History Code Too Soon
This is a particularly important documentation issue. The word “history” is sometimes used casually in medical records.
A provider may write “history of breast cancer” simply because the cancer was diagnosed several years earlier, even though the patient is still receiving treatment directed at the malignancy. Coding status isn’t determined simply by how long ago the diagnosis occurred.
Review the documentation and applicable ICD-10-CM guidelines to determine whether the malignancy is active or whether a personal-history code is appropriate. When the status isn’t clear enough to make that determination, provider clarification may be necessary.
Treatment Can Help Determine Sequencing
Once you’ve identified the primary and secondary malignancies, you still need to determine the appropriate sequencing. There isn’t one universal rule saying: “Always code the primary cancer first.”
Nor should you automatically put the secondary malignancy first. Sequencing can depend on the reason for the encounter, the treatment being provided, and applicable ICD-10-CM neoplasm guidelines.
For example, an encounter focused specifically on treatment of a secondary malignancy may be coded differently from an encounter focused on treatment of the primary cancer.
Encounters for chemotherapy, immunotherapy, radiation therapy, complications, or other circumstances may also have their own sequencing requirements. Before determining the first-listed diagnosis, ask: “What is the reason for this encounter?” Then apply the appropriate ICD-10-CM sequencing instructions.
Don’t Forget the Neoplasm Table
The ICD-10-CM Neoplasm Table is an important tool for locating neoplasm codes. It organizes codes based on the anatomical site and classification of the neoplasm, including distinctions such as primary and secondary malignant neoplasms.
But don’t stop there. After using the Neoplasm Table to locate a potential code, verify the selection in the Tabular List. Review the complete description and any applicable instructional notes.
Use the table to help find the code. Use the Tabular List to help verify it.
Don’t Code Directly From the Neoplasm Table
This is worth making a routine. A coder identifies the anatomical site, finds a code in the Neoplasm Table, enters it into the claim, and moves on. That’s incomplete.
Always verify the potential code in the Tabular List before finalizing your selection. That verification can help you catch additional instructions, exclusions, specificity requirements, or other information that affects accurate reporting.
A Safer Coding Workflow
Documentation → Neoplasm Table → Tabular List → Instructions → Final Code
Watch for Multiple Metastatic Sites
Cancer doesn’t always spread to only one location. A patient may have one primary malignancy with metastases involving multiple secondary sites. When the documentation supports multiple secondary malignancies, each site may need to be evaluated and coded appropriately.
Don’t collapse multiple documented metastatic sites into one generic statement of “metastatic cancer” if ICD-10-CM and the documentation support more precise reporting.
At the same time, don’t infer additional metastases simply because they’re common for that type of cancer. Every reported site needs documentation support.
Documentation Should Tell the Cancer Story
Strong oncology documentation helps a coder answer several basic questions:
- Where did the malignancy originate?
- Where has it spread?
- Is the primary malignancy still active?
- Which metastatic sites are currently present?
- What is being treated today?
- Are there complications or manifestations that also require coding?
When those questions are answered clearly, coding becomes much more straightforward. When they’re not, the coder shouldn’t attempt to reconstruct the patient’s cancer story from assumptions.
Use the SPREAD Test When Coding Metastatic Cancer
Use the SPREAD Test when coding metastatic cancer.
S — SITE: What anatomical site is involved?
P — PRIMARY: Where did the malignancy originate?
R — RELATIONSHIP: Does the documentation clearly establish that the cancer spread from the primary site?
E — EXISTING DISEASE: Is the primary malignancy still active, or is it appropriately considered a history?
A — ADDITIONAL SITES: Are other secondary malignancies documented?
D — DRIVER OF THE ENCOUNTER: Which condition or treatment is responsible for today’s encounter, and what do the sequencing guidelines require?
Then: Verify in the Tabular List before assigning the final codes.
Real Practice Example
A patient previously diagnosed with colon cancer is now being treated after imaging and oncology documentation identify metastatic disease involving the liver. The oncologist documents: “Colon adenocarcinoma metastatic to liver.”
That documentation establishes the relationship between the sites. The coder can evaluate the appropriate primary colon malignancy code and the secondary malignant neoplasm code for the liver, along with the reason for the current encounter and applicable sequencing rules.
Now consider a different note: “History of colon cancer. Liver mass suspicious for malignancy.”
That’s not the same documentation. The coder shouldn’t convert a suspicious liver mass into metastatic colon cancer.
Likewise, the coder shouldn’t assume that a confirmed liver malignancy is secondary to the prior colon cancer unless the provider establishes that relationship.
The patient’s medical history may make metastasis seem likely. Likely isn’t the same thing as documented.
Frequently Asked Questions
What Is the Difference Between a Primary and Secondary Malignant Neoplasm?
The primary site is where the cancer originated. A secondary malignant neoplasm represents cancer that has spread from its primary site to another anatomical location.
Does Metastatic Cancer Mean Secondary Malignant Neoplasm?
Metastatic disease generally refers to cancer that has spread from its primary site. Code the secondary site based on the provider’s documentation and applicable ICD-10-CM classification and guidelines.
Can You Assume a New Cancer Site Is Metastatic if the Patient Already Has Cancer?
No. Don’t establish a primary-secondary relationship simply because the patient has malignancies at two sites. The documentation needs to support the relationship.
Can a Patient Have a History of a Primary Cancer and an Active Secondary Malignancy?
Yes. Depending on the circumstances, the original primary malignancy may meet the requirements for a personal-history code while metastatic disease remains active elsewhere.
Do You Always Code the Primary Malignancy First?
No. Sequencing depends on the reason for the encounter and applicable ICD-10-CM guidelines. Don’t automatically sequence the primary malignancy first.
Can You Code a Secondary Malignancy if the Primary Site Is Unknown?
The fact that the primary site isn’t known doesn’t necessarily prevent coding a documented secondary malignancy. Code what the documentation supports and apply the appropriate ICD-10-CM guidelines for the circumstances.
Should You Code Directly From the Neoplasm Table?
No. Use the Neoplasm Table to help locate the appropriate code, then verify the selection in the Tabular List and review applicable instructions.
What If the Provider Doesn’t Clearly Say Whether the Cancer Is Primary or Secondary?
Don’t guess. Review the documentation, and when the distinction remains unclear and affects accurate coding, determine whether a compliant provider query is appropriate.
Secondary Malignant Neoplasm Coding Checklist
Bottom Line
Secondary malignant neoplasm coding begins with understanding the patient’s cancer story.
Don’t assume that a malignancy at a second site is metastatic simply because the patient already has cancer. Determine where the malignancy originated, where it spread, whether the primary cancer remains active, and what is driving the current encounter.
Follow a Consistent Process
Identify Primary Site → Confirm Secondary Site → Establish the Relationship → Determine Cancer Status → Review the Encounter → Verify the Codes → Apply Sequencing Rules
The goal isn’t merely to report that the patient has cancer. It’s to accurately represent where the cancer originated, where it has spread, and what the documentation supports.
Key Takeaways
- A primary malignancy is the site where the cancer originated.
- A secondary malignant neoplasm is cancer that has spread to another site.
- Don’t assume two documented cancers have a primary-secondary relationship.
- Look for documentation establishing metastasis or spread.
- Code the secondary site as specifically as the documentation supports.
- Determine whether the primary cancer remains active or is appropriately represented by a personal-history code.
- Don’t automatically use a history code simply because the patient isn’t currently receiving treatment at the primary site.
- Sequencing depends on the circumstances of the encounter and applicable ICD-10-CM guidelines.
- Review the Neoplasm Table, but verify the final code in the Tabular List.
- Query the provider when the relationship or status of the malignancy isn’t clear enough to code accurately.
Help Your Team Handle Complicated Cancer Coding With Confidence
Cancer coding can quickly become complicated when your team must distinguish primary from secondary malignancies, determine whether cancer remains active, identify metastatic sites, and apply the correct sequencing rules.
Healthcare Training Leader’s All-Access Training Pass gives your team practical, expert-led training covering ICD-10-CM, CPT, E/M coding, billing, reimbursement, compliance, payer requirements, and other challenges that directly affect your practice’s revenue.
Give your team the knowledge to translate complicated clinical documentation into accurate, defensible diagnosis coding.
Why Trust Healthcare Training Leader?
Healthcare Training Leader has helped more than 68,000 healthcare professionals at 10,000+ practices strengthen their skills and tackle the operational, financial, coding, and compliance challenges they face every day.
Our expert-led training focuses on turning complicated coding and reimbursement requirements into clear, actionable guidance your team can put to work.
Meet Your Expert
Keisha Wilson
As the founder and CEO of KW Advanced Consulting and a national and regional conference speaker, Keisha Wilson has led the way in healthcare for nearly 30 years. Her experience in large teaching hospitals and acute ambulatory care systems, along with her roles as an outpatient coding specialist, clinical documentation improvement (CDI) specialist, compliance operations coding and billing manager, interim compliance director, and consultant, demonstrates her leadership and deep understanding of the industry.
Keisha is not only a subject matter expert in Compliance and Revenue Cycle Management, but also a dedicated educator and trainer. She excels in Risk-Based Audits, Retrospective, Prospective, Evaluation and Management audits, as well as in the auditing and coding of multi-specialty, documentation, and coding for Telehealth/Telemedicine services, Risk Adjustment/HCC provider and coder education/training, and webinars. Keisha has developed and implemented numerous compliance documentation and coding training programs for organizations of all sizes. She is an approved instructor for KW Advanced Consulting and an adjunct instructor for NYC College of Technology and the American Academy for Professional Coders (AAPC), where she teaches a wide range of compliance and coding courses.
Keisha's dedication to sharing her expertise extends beyond her professional roles. She serves on the board of directors for an outpatient mental health clinic and actively participates in various telehealth and compliance committees, as well as the Advisory Nursing Board. As a published author, she regularly contributes coding articles for KW Advanced Consulting, keeping the industry updated with the latest developments. Her collaboration with the AAPC editors on various articles for AAPC Magazine (formerly Healthcare Business Monthly) is a testament to her commitment to advancing the field.
Additional Resources
-
How Do Medical Coders Calculate HCPCS Units for Injectable Drugs?
Incorrect HCPCS drug units can lead to denials, underpayments, and compliance risks. Find out how to convert injectable medication doses into billing units, avoid vial and concentration errors,...
-
Stop Revenue Losses Under the 2027 CPT Maternity Care Coding Restructure
REVIEW REQUIRED: JANUARY 1, 2027 Effective January 1, 2027, how you bill for maternity services will dramatically change. If your practice continues to submit claims using the traditional...
-
CMS Gives OB-GYN Practices Temporary Relief From 2027 Maternity Billing Changes
Your OB-GYN practice may have patients receiving prenatal care today who won’t deliver until 2027. That creates a billing challenge because the CPT codes used to report maternity...
